CREATE Study
Advancing Care, Transforming Lives
CREATE Study
C3G ICGN Real-World Evidence to Advance Transformative Care Study
A join venture between GlomCon and Novartis
About the Study
CREATE Study is a collaborative initiative to advance transformative care for patients with C3G and IC-MPGN.
​
With your participation, we aim to create a robust database, in collaboration with key academic and community medical centers, to advance knowledge and real-world evidence for these rare diseases.
​
All co-investigators will have the opportunity to leverage the data platform to pursue epidemiological and observational clinical effectiveness studies.
Join us a funded co-investigator to
Engage in global scientific collaborations.
Participate in the forefront of clinical research.
Become a member of GlomCon's Investigator Network.
Advance the care for C3G and primary IC-MPGN patients.
C3G and IC-MPGN are rare kidney disorders that present significant diagnostic and therapeutic challenges.
​
As a clinical investigator, you can impact patient outcomes by joining a global effort to build a robust epidemiological registry.
​
Contribute to Real-World Evidence: Help gather critical data and provide invaluable insights into C3G and IC-MPGN.
​
Shape the Future of Care: Collaborate with leading nephrologists to shape patient care for C3G and IC-MPGN.
​
Expand Your Site's Role in Clinical Research: Participate in a prestigious multi-site study and support the professional development of early-career nephrologists.
​
Access to Cutting-Edge Resources: Gain access to a secure, HIPAA-compliant, and FDA-approved platform for efficient data capture and management for this study, your own research projects, and beyond.
​
Funding Opportunities Available: Partnering sites will receive financial support.
Sign up today
If you are interested in participating, scan the QR code or email rica.pitogo@glomcon.org
.png)